CX-4945

You have access
Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro
JOMNARONG LERTSUWAN, ANYAPORN SAWASDICHAI, NATHAPOL TASNAWIJITWONG, KEVIN GASTON, PADMA-SHEELA JAYARAMAN and JUTAMAAD SATAYAVIVAD

Anticancer Research December 2021, 41 (12) 6155-6167; DOI: https://doi.org/10.21873/anticanres.15435
You have access
Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate Reductase Results in Synergistic Effect on Acute Lymphoblastic Leukemia Cells
PATRYCJA WIŃSKA, ŁUKASZ WIDŁO, KATARZYNA SKIERKA, ALICJA KRZYŚKO, MIROSŁAWA KORONKIEWICZ, JAROSŁAW M. CIEŚLA, JOANNA CIEŚLA and MARIA BRETNER

Anticancer Research July 2019, 39 (7) 3531-3542; DOI: https://doi.org/10.21873/anticanres.13499
You have access
Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer
HYUN MYONG KIM, INHYE JEONG, HYUN JEONG KIM, SUN KYOUNG KANG, WOO SUN KWON, TAE SOO KIM, KYU HYUN PARK, MINKYU JUNG, JOHN SOONG, SHU-CHUAN LIN, HYUN CHEOL CHUNG and SUN YOUNG RHA

Anticancer Research November 2018, 38 (11) 6171-6180; DOI: https://doi.org/10.21873/anticanres.12970
You have access
Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells
PATRYCJA WIŃSKA, KATARZYNA SKIERKA, EDYTA ŁUKOWSKA-CHOJNACKA, MIROSŁAWA KORONKIEWICZ, JOANNA CIEŚLA and MARIA BRETNER

Anticancer Research August 2018, 38 (8) 4617-4627; DOI: https://doi.org/10.21873/anticanres.12766

Main menu

User menu

Search

CX-4945